TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, and THE BANK OF NEW YORK MELLON, as Trustee FOURTH SUPPLEMENTAL SENIOR INDENTURE Dated as of March 9, 2023 to the Senior Indenture dated...Fourth Supplemental Senior Indenture • March 9th, 2023 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 9th, 2023 Company Industry JurisdictionFOURTH SUPPLEMENTAL SENIOR INDENTURE, dated as of March 9, 2023, by and among Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”) and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”)
TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, THE BANK OF NEW YORK MELLON, as Trustee and THE BANK OF NEW YORK MELLON, LONDON BRANCH, as Paying Agent FOURTH SUPPLEMENTAL SENIOR...Fourth Supplemental Senior Indenture • March 9th, 2023 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 9th, 2023 Company Industry JurisdictionFOURTH SUPPLEMENTAL SENIOR INDENTURE, dated as of March 9, 2023, by and among Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”) and The Bank of New York Mellon, London Branch, as paying agent (the “Paying Agent”).